They reported that NCT-503 slowed proliferation of neuroblastoma in vivo but had a limited effect in killing cells; they concluded that PHGDH inhibition has limited potential as a treatment option for neuroblastoma. This evidence concerns the gene PHGDH and neuroblastoma.